The oncologic benefit of liver resection for colorectal liver metastases (CRLM) in the setting of concurrent extrahepatic disease (EHD) is controversial. We performed a population‐based, cross‐sectional study to determine the… Click to show full abstract
The oncologic benefit of liver resection for colorectal liver metastases (CRLM) in the setting of concurrent extrahepatic disease (EHD) is controversial. We performed a population‐based, cross‐sectional study to determine the practice patterns and overall survival (OS) of patients with CRLM + EHD who underwent liver resection.
Keywords:
extrahepatic disease;
population based;
liver resection;
resection
Journal Title: Journal of Surgical Oncology
Year Published: 2024
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of Surgical Oncology
Year Published: 2024
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!